Glenn J Hanna, MD
Dana-Farber Cancer Institute
3
3
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Vivek Subbiah, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Alan Ho, MD, PhD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Charalampos Floudas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Aung Naing, Md
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Matthew Krebs, Dr
The Christie Hospital
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Nina Bhardwaj, MD, PhD
Icahn School of Medicine at Mount Sinai
Shared therapeutic areas:
David Hui, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Francesco Perrone, M.D., Ph.D.
NCI Naples, Clinical Trials Unit
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Cemiplimab in AlloSCT/SOT Recipients With CSCC
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
All 3 trials loaded